Search

everythinglearnresearchcommunity

for

Search:↓

The treatment improved acne, seborrhoea, and hirsutism, with some side effects like spotting and nervousness.

Baricitinib is effective and safe for treating severe alopecia areata with ongoing use.

Talc in street cocaine can cause immune-reactive skin nodules where injected.

Continued ritlecitinib treatment can improve hair regrowth in some alopecia areata patients who initially don't respond.

The rs1128977 gene variant may affect cholesterol and body measurements.

Cyclic ADP-ribose helps regulate calcium and signals that promote hair growth in hair follicle cells.

Scientists made a chemical (compound 4e) that can be applied on skin to reduce oil production, which can help with acne, but it might cause skin sensitivity to light.

Prostaglandin E2 helps prevent hair loss from radiotherapy by protecting hair growth cells and aiding self-repair.

Blocking α-toxin helps heal Staphylococcus aureus-infected wounds faster in both normal and diabetic mice, with different effects on their immune responses.

New cancer treatments show promise in reducing tumor growth and improving skin regeneration in mice.

Upadacitinib improved Crohn's disease, atopic dermatitis, and alopecia areata in one patient.

Abemaciclib can cause skin, hair, and nail problems, leading some patients to stop using it.

Nemolizumab improved both severe atopic dermatitis and alopecia areata in one patient.

Baricitinib combined with other immune therapies may safely and effectively treat severe scalp hair loss.

Agaricus bisporus β-Glucan particles could effectively treat cervical cancer and offer antimicrobial and antioxidant benefits.

The research found how GPCR Class A Rhodopsin receptors are related and suggested possible substances they interact with.

Ritlecitinib is generally safe for adolescents with alopecia areata over 5 years.

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

Agouti protein affects melanocortin receptors through competitive antagonism and receptor down-regulation.

RTA 408 cream protects mice from radiation skin damage.

Ritlecitinib shows promise for hair regrowth in alopecia areata patients.

Skin side effects from CDK4/6 inhibitors in breast cancer patients are generally mild and treatable, allowing most patients to continue treatment.

The new Hairless R/J mice model improves imaging for tumor monitoring and cancer therapy evaluation.

Abrocitinib shows promise for treating various skin conditions beyond atopic dermatitis.

Roxithromycin, an antibiotic, can increase hair growth and might be used as a treatment for hair loss.

Upadacitinib can effectively regrow hair in alopecia areata patients without worsening sarcoidosis.

JAK inhibitors effectively regrow hair in alopecia areata but hair loss often returns after stopping treatment.

Ruxolitinib effectively regrows hair in most patients with severe hair loss.

Cyclosporin A, a drug, reduces TGF-β2 expression in skin cells, potentially causing excessive hair growth through a process involving the calcineurin/NFAT pathway.

A new drug, abrocitinib, helped a child with severe hair loss regrow hair.